home
docs

Canada Access to anti-retroviral drugs, female (%) 2026: Interactive Chart & Historical Data

Access to anti-retroviral drugs, female (%) in Canada stood at 72% in 2022, according to World Bank. The latest value is down 2 percentage points from 74% in 2021. Ten years earlier, in 2012, the value was 48% (up 24 percentage points since). The highest value since 2000 was 75% in 2018, the lowest 14% in 2000. Canada ranked 66th highest of the 138 countries in this dataset in 2022; Benin ranked first.

Data source: World Bank · Unit: % · Category: Demographics · Explore more indicators on EconDash

Data updated:Last checked:Frequency:AnnualCoverage:2000–2024

Key facts

What is the latest Access to anti-retroviral drugs, female (%) in Canada?

Access to anti-retroviral drugs, female (%) in Canada stood at 72% in 2022, according to World Bank.

Is Access to anti-retroviral drugs, female (%) in Canada rising or falling?

The latest value is down 2 percentage points from 74% in 2021. Ten years earlier, in 2012, the value was 48% (up 24 percentage points since).

How does Canada rank for Access to anti-retroviral drugs, female (%)?

Canada ranked 66th highest of the 138 countries in this dataset in 2022; Benin ranked first.

What is the highest Access to anti-retroviral drugs, female (%) on record in Canada?

The highest value since 2000 was 75% in 2018, the lowest 14% in 2000.

Metadata for Access to anti-retroviral drugs, female (%) in Canada
IndicatorAccess to anti-retroviral drugs, female (%)
CountryCanada
CategoryDemographics
Unit%
SourceWorld Bank
Interactive chartView on EconDash
API accessEconDash API documentation

Latest value: 72% (2022)

Loading chart...

Source:World Bank — series SH.HIV.ARTC.FE.ZS
License:CC BY 4.0
Cite this chart
APA

World Bank. (2026). Access to anti-retroviral drugs, female (%) — Canada [Data set]. Retrieved November 13, 2026, from EconDash: https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/CAN. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS?locations=CA

MLA

World Bank. "Access to anti-retroviral drugs, female (%) — Canada." EconDash, 2026, https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/CAN. Accessed 13 Nov. 2026. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS?locations=CA.

Chicago

World Bank. 2026. "Access to anti-retroviral drugs, female (%) — Canada." EconDash. Accessed November 13, 2026. https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/CAN. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS?locations=CA.

BibTeX
@misc{econdash_wdi_sh_hiv_artc_fe_zs_can,
  author = {{World Bank}},
  title = {{Access to anti-retroviral drugs, female (\%) --- Canada}},
  howpublished = {EconDash},
  year = {2026},
  url = {https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/CAN},
  note = {Accessed: 2026-11-13. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS?locations=CA}
}